UNLIMITED TURBO SHORT - ABBOTT LABORATORIES Stock

Certificat

DE000PF50J89

Market Closed - Deutsche Boerse AG 15:50:33 2024-05-24 EDT
3.5 EUR +1.16% Intraday chart for UNLIMITED TURBO SHORT - ABBOTT LABORATORIES
Current month+4.48%
1 month+7.36%
Date Price Change
24-05-24 3.5 +1.16%
24-05-23 3.46 +0.58%
24-05-22 3.44 -4.18%
24-05-21 3.59 +1.13%
24-05-20 3.55 +2.01%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 03:50 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PF50J8
ISINDE000PF50J89
Date issued 2021-01-15
Strike 141.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.04
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.28
Lowest since issue 0.81

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104 USD
Average target price
125.7 USD
Spread / Average Target
+20.92%
Consensus